NCT00035191View on ClinicalTrials.gov

A Placebo-controlled Trial to Evaluate the Safety and Efficacy of Galantamine in the Treatment of Vascular Dementia

PHASE3CompletedINTERVENTIONAL
Enrollment

254

Participants

Timeline

Start Date

October 31, 2001

Study Completion Date

September 30, 2003

Conditions
Dementia, Vascular
Interventions
DRUG

galantamine

All Listed Sponsors
lead

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

INDUSTRY

NCT00035191 - A Placebo-controlled Trial to Evaluate the Safety and Efficacy of Galantamine in the Treatment of Vascular Dementia | Biotech Hunter | Biotech Hunter